Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol 2010 Jun;3(3):255-60

Date

11/19/2010

Pubmed ID

21082977

Pubmed Central ID

PMC3793890

DOI

10.1586/ehm.10.22

Scopus ID

2-s2.0-77953494025 (requires institutional sign-in at Scopus site)   81 Citations

Author List

Brandow AM, Panepinto JA

Author

Amanda Brandow DO Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Anemia, Sickle Cell
Antisickling Agents
Blood Transfusion
Child
Drug Monitoring
Fear
Female
Hematopoietic Stem Cell Transplantation
Humans
Hydroxyurea
Male
Patient Compliance
Patient Freedom of Choice Laws
Risk Assessment
Treatment Outcome
Young Adult